The ICE U.S. Dollar Index was up 0.4% in recent trading after the latest reports about President Donald Trump's tariff plans.

IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.

Disclaimer: The analyst who wrote this piece owns shares of Strategy (MSTR).Strategy (MSTR) expects its convertible preferred ...

With hopes of a soft economic landing and a rebound in initial public offerings, Nasdaq’s stock market welcomed 162 new listings in the fourth quarter, up from 100 a year earlier. That helped ...

We recently published a list of the 10 Best Furniture Stocks to Buy Right Now. In this article, we are going to take a look ...

Nauticus Robotics, Inc., a company specializing in industrial machinery and equipment, has been actively taking measures to ...